Last reviewed: July 3, 2026
Last updated: July 3, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has shown remarkable weight loss results in clinical trials, with patients losing 15% of body weight on average. Understanding how dosing works—and how your dose may increase over time—helps you plan your weight loss journey with confidence. PlexusDx makes this accessible with compounded semaglutide from licensed 503A pharmacies and transparent, flat-rate pricing.
Understanding Semaglutide Dosing for Weight Loss
Semaglutide for weight loss uses a step-up dosing schedule designed to minimize side effects while maximizing results. The typical protocol starts at 0.25 mg once weekly for the first four weeks, then increases by 0.25 mg each month until reaching a therapeutic maintenance dose, usually between 2.0 mg and 2.4 mg weekly. This gradual approach allows your body to adapt and helps your healthcare provider identify the dose that works best for your individual metabolism and tolerance.
The escalation phase typically spans 16 weeks, but timing can vary based on how well you tolerate each dose level. Some patients reach their target dose in fewer increments, while others benefit from staying at intermediate doses longer. PlexusDx works with you to determine the right pace for your body, without charging more as your dose increases—your monthly investment stays the same.
Starting Dose vs. Maintenance Dose: What's the Difference?
The starting dose of 0.25 mg is intentionally low and is never meant to be a therapeutic weight loss dose on its own. This initial injection sensitizes your system to semaglutide and allows your clinician to observe your response before moving to higher doses. Most weight loss studies show meaningful results begin at doses of 1.0 mg or higher, which is why the step-up schedule is a critical part of the treatment plan.
Maintenance doses for weight loss typically range from 2.0 mg to 2.4 mg weekly, though some patients achieve their goals at slightly lower doses like 1.5 mg. Your maintenance dose is the one you'll continue long-term to sustain weight loss and metabolic improvements. PlexusDx's flat monthly pricing means whether you're at 0.25 mg in week one or 2.4 mg after four months, your cost remains consistent at $149 per month.
How Long Does It Take to Reach Your Target Dose?
Reaching a therapeutic maintenance dose typically takes 16 weeks on the standard escalation schedule. This four-month timeline allows your body to gradually adjust to semaglutide's effects on appetite regulation, digestion, and blood sugar control. Rushing through dose increases can lead to stronger side effects like nausea or gastrointestinal discomfort, so the step-up approach prioritizes both safety and comfort.
Once you reach your target maintenance dose, you'll continue that same weekly injection indefinitely while you're pursuing weight loss. Some patients choose to stay on semaglutide long-term to maintain their results, while others transition off under medical supervision once they've reached their goal. The timeline is individual, and PlexusDx's clinicians work with you to create a plan that matches your objectives and lifestyle.
Compounded Semaglutide vs. Brand-Name Options: Why Dosing Remains the Same
Compounded semaglutide from licensed 503A pharmacies contains the same active ingredient and follows the same clinical dosing protocols as brand-name Ozempic or Wegovy. The dosing schedule, escalation timeline, and maintenance levels are medically identical—the difference lies in cost, accessibility, and availability. PlexusDx sources its compounded semaglutide from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality while eliminating the markup of brand-name distribution.
One critical advantage of PlexusDx's compounded semaglutide is transparent, flat-rate pricing: your dose may increase over four months, but your monthly cost stays at $149. This pricing model removes the financial barriers that prevent many patients from accessing semaglutide therapy. Additionally, PlexusDx serves all 50 states with no insurance requirement, no membership fees, and HSA/FSA eligibility, making weight loss treatment accessible regardless of your insurance status.
Personalizing Your Dosing Plan with Genetic Insights
Your genetic makeup influences how effectively your body responds to semaglutide and which dose may work optimally for your metabolism. PlexusDx's Precision Peptide Genetic Test analyzes 49 peptides across 14 metabolic pathways, including key variants like GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. These genetic markers affect your appetite regulation, insulin sensitivity, and how your body processes GLP-1 receptor signals.
Understanding your genetic profile allows PlexusDx clinicians to anticipate your response to semaglutide and potentially refine your dosing timeline or maintenance target. For example, if your genetics suggest heightened GLP-1 sensitivity, you might achieve results at a lower maintenance dose, while others with specific FTO variants may benefit from a more gradual escalation. The Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment, making personalized dosing science accessible without major additional cost.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does the dose really not go up in price with PlexusDx?
Yes—PlexusDx's compounded semaglutide injection starts at $149 per month and stays at that flat rate regardless of whether you're at 0.25 mg or your maintenance dose of 2.0 mg or higher. Your dose may need to go up. Your price won't. This pricing model removes a major barrier to completing your full dosing protocol without financial surprises.
What weight loss results can I expect at different dose levels?
Clinical trials show meaningful weight loss begins around 1.0 mg to 1.5 mg weekly, with average losses of 5–10% of body weight at those levels. At maintenance doses of 2.0–2.4 mg, average weight loss reaches 15% or higher. Individual results vary based on diet, exercise, genetics, and adherence, but the step-up dosing schedule is designed to reach doses where evidence-based results become consistent.
Can I skip dose increases or stay at a lower dose?
Yes—your PlexusDx clinician will work with you to adjust your escalation pace based on side effects, tolerance, and your personal goals. Some patients find their target dose earlier than the standard 16-week timeline, while others prefer a slower increase. The protocol is flexible, and staying at a sub-maintenance dose is medically valid if it aligns with your comfort and objectives.
Are there side effects at lower doses that improve as I escalate?
Many patients experience mild nausea or appetite changes during the first few weeks at each new dose level, but these effects typically resolve within 3–5 days as your body adapts. The gradual escalation schedule is specifically designed to minimize side effect burden. If side effects persist or become severe, your PlexusDx clinician can slow your escalation or adjust your approach without increasing your monthly cost.
How does genetic testing help with dosing decisions?
PlexusDx's Precision Peptide Genetic Test identifies your genetic predispositions across 49 peptides and 14 metabolic pathways, including GLP-1 sensitivity genes. If your results show high GLP-1 receptor sensitivity, your clinician may anticipate good results at lower maintenance doses. Conversely, certain FTO or MC4R variants may suggest you'll benefit from reaching higher therapeutic doses or a specific escalation timeline. This science-backed personalization optimizes your outcome and confidence.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding Zepbound Side Effects and Their Duration
Navigating Zepbound Dosing: Why Precision is Paramount and Can You Take 2 Zepbound 2.5 mg at Once?